Microbial Identification Market

Global Microbial Identification Market Size (2024 to 2029)

The global microbial identification market size is valued at USD 1.83 billion in 2024 and is expected to reach USD 2.49 billion by 2029, growing at a CAGR of 6.3% during the forecast period. 

Microbial identification entails identifying various microorganisms prone to cause different infectious conditions in humans. In the present world, the major types of microorganisms that cause diseases are parasites, bacteria, fungi and viruses. Their presence contaminates the manufacturing facilities, raw materials and food products. The practical use of classification criteria to verify the authenticity of a particular strain, distinguish some organisms from others, and isolate and identify the organism causing the sickness is called identification. In a true sense, microbial identification is a precise characterization through an appropriate test method of a given microorganism, capable of returning the name of the species tested. Genotypic, proteotypic and phenotypic are the methods used for microbial identification.

MARKET DRIVERS

The rising prevalence of infectious diseases majorly propels the growth of the global microbial identification market.

Infectious diseases are one of the major causes of death worldwide. WHO says an estimated 17% of the deaths worldwide have a connection with infectious diseases. Respiratory infections such as influenza and pneumonia, diarrheal diseases, HIV/AIDS, tuberculosis, malaria and hepatitis are some of the notable infectious diseases. The importance of accurate and rapid identification of microorganisms that cause infectious diseases has increased significantly in the recent past. The appropriate identification is essential to plan treatment procedures and control the spread of the diseases and take effective infection control measures. Microbial identification is a promising approach that identifies specific pathogens responsible for infections and helps healthcare professionals to choose appropriate antimicrobial therapy and implement targeted infection control measures. The timely and accurate identification of microorganisms is extremely important to avoid morbidity, mortality and high healthcare costs.

Technological advancements contribute to the growth rate of the microbial identification market. The microbial identification approach has experienced several technological advancements in the recent past. Advanced microbial identification technologies such as molecular techniques, DNA sequencing, and mass spectrometry have improved the speed, accuracy and reliability of microbial identification considerably. Due to these technological advancements, the adoption of microbial identification systems in various healthcare settings has increased significantly. This trend is likely to continue in the coming years and contribute to the market growth.

The growing usage of microbial identification to ensure food safety by detecting and identifying microbial contaminants in food products fuels market growth. There has been an increase in concerns regarding foodborne illnesses and regulations for food safety, which has fuelled the usage of microbial identification. The demand for microbial identification solutions in the food industry has grown substantially in the recent past. This trend is predicted to continue in the coming years and favor market growth.

The growing number of R&D activities in microbiology and microbial identification, rising emphasis on understanding the microbiome and its impact on human health, agriculture and the environment, growing usage of microbial identification in the pharmaceutical and biotechnological sectors for the R&D of drugs, vaccines and biologics and increasing demand for automated microbial identification systems to reduce human errors and improve workflow efficiency promotes the market growth. An increasing number of initiatives and regulations from the regulatory bodies that emphasize the importance of accurate microbial identification, the growing need for antimicrobial resistance and the increasing need for appropriate antimicrobial therapy and the rising demand for point-of-care microbial identification systems further contribute to the market’s growth rate.

MARKET RESTRAINTS

Limitations of NGS in clinical microbiology might be the inability to detect the correct pathogen causing disease, unclear antibiotic resistance, high cost, and unknown clinical utility.

Also, it is essential to understand that no single test methodology will provide 100% accurate results since any system used to identify bacteria will have limitations, whether phenotypic or genotypic. Automated microbial detection devices are more expensive and have more sophisticated features and functions—MALDI-TOF MS-based device costs. The consumables used in identification procedures are often costly, as is the work involved.

Many recent rapid experiments also required higher capital, considerably higher than traditional cultural approaches. The average cost of tools, media, and labor is disproportionately high for specific end-users due to their small budgets; academic research laboratories cannot purchase such systems. The use of microbial detection methods generally requires the use of qualified professionals, and the lack of trained professionals impedes the development of the microbial sector.

Microbial detection methods such as gene sequencing, for instance, provide quick results but require money and trained personnel, restricting their use. Another shortcoming of conventional microbial detection is the inability of pathogenic viruses to be detected by traditional culture and biochemical profiling, leading to false negative results for patients. Also, the weakness goes beyond bacteria, as it might be challenging or impossible to identify viruses and fungi using conventional culture techniques. However, as it does not involve culturing or isolating germs before identification and can discover antibiotic resistance genes without the different bacteria cultures for susceptibility testing, NGS-based detection can offer a substantial advantage over conventional approaches.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Microbial Identification Market Analysis By Method 

Based on the method, the phenotypic method segment is anticipated to hold the leading market share during the forecast period because of its accuracy over the traditionally utilized Genotypic method. The phenotype is the set of all the expressed characteristics, and its identification is the different methods focusing on observable characteristics like biochemical attributes, physiology, and morphology of microorganisms. It involves microscopy to know the cell shape, Gram statuses cell structures such as flagella, and culture requirements such as oxygen, osmotic pressure, and temperature.

The proteomics segment is another promising segment. Proteomics is the study of proteins on a large scale. This is also expected to dominate the segment. Proteins are essential components of living organisms that have a variety of roles. Proteomics refers to the large-scale laboratory study of proteins and proteomes in general, but it is often used to refer to protein purification and mass spectrometry. Proteomics has accelerated due to advances in large-scale nucleotide sequencing of expressed gene tags and genomic DNA. However, this information could only represent proteins, even with advances in MS.

Global Microbial Identification Market Analysis By Application 

Based on application, the diagnostic segment accounted for a significant market share in 2022 because of the globally increasing concern about health. However, the growing geriatric population, which has resulted in a rise in the prevalence of chronic and infectious diseases, contributes to the segment's growth. A potential tool for microbial identification and diagnosis, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, emerged recently to identify rRNA and 18S rRNA gene sequencing in a much possible and efficiently more straightforward manner.

The F&B segment is estimated to play a notable role in the global microbial identification market during the forecast period owing to its great importance in microbiological analysis for identifying the pathogens responsible for food spoilage, which makes it an essential part of food microbiology for the consumer safety, minimizing costly mitigation measures, and prevent brand spoilage due to failed inspections, resulting in food poisoning outbreaks.

Global Microbial Identification Market Analysis By Product                       

The instruments segment is the top market share contributor globally based on product. The instrument segment growth is attributed to technological advancements in microbial identification, the proliferation of infectious diseases, growing food safety concerns, and prominent players worldwide. An IVD-certified instrument, ChromaZona, is designed to automate microbial identification and expedite testing in the clinical laboratory and for antibiotic susceptibility testing.

Microbial Identification Market By End User

Based on end-user, the hospitals and diagnostic centers segment led the global market in 2023, owing to the high incidence of various microbial infections. The rising geriatric population base, demand for HAI diagnostics from middle and low-income countries, and technologically advanced diagnostic products are all factors moving the HAI diagnostics market forward. When a specific agent is suspected of being present in a human sample, the hospital clinical microbiology laboratory "wakes up" to support a biothreat, crime, or act of bioterrorism. Local first responders have contacted numerous hospital-based clinical microbiology labs to conduct tests for dust and other environmental contaminants. Additionally, this position actively participates in epidemiology and surveillance.

Microorganisms play an essential role in the food industry, which might make the food manufacturing Industries dominate the segment. Although microbes are used in the preparation of various food products, they also deteriorate the food, leading to poisoning and disease. Food products are frequently contaminated by microorganisms throughout the transfer from the field to the processing facility, during processing, storage, transport, distribution, and before consumption.

REGIONAL ANALYSIS

Due to the developed healthcare industry, the North American microbial infection market contributed significantly to the global market in 2023. North America is expected to dominate the microbial identification market over the forecast period due to factors such as the rising prevalence of various diseases, rising healthcare expenditures, increasing development of microbial identification techniques, increasing burden of infectious diseases, presence of key players, presence of well-established healthcare infrastructure, and growing concerns regarding food safety makes North America the biggest revenue generator in this market, followed by Europe.

The microbial identification market of Europe is anticipated to hold a substantial share of the global market due to growing opportunities in the global microbial identification market, the growing need to improve the quality of food and pharmaceutical products, the growing prevalence of infectious diseases in the region, and the availability of advanced testing solutions.

The microbial identification market in the Asia-Pacific is also anticipated to hold a significant market share through the increasing initiatives to control the spread of infectious diseases, an increasing number of FDA approvals primarily by countries like China, improvements in healthcare infrastructure, increase in technological advancements due to the heavy burden of infectious diseases, the significant presence of prominent manufacturers, vital government initiatives, and increasing investments for ongoing projects. Furthermore, because of the rising amount of money spent on healthcare in emerging countries in the region, the Asia Pacific market is calculated to grow with the highest growth rate. In addition, the increased investment from significant players growing percentage of infectious diseases is making China a leading market, which is highly lucrative for microbial identification market growth.

The Latin America microbial identification market is predicted to account for a considerable share of the global market during the forecast period.

The microbial identification market in MEA is estimated to grow at a steady CAGR during the forecast period.

KEY MARKET PARTICIPANTS

Some of the notable companies operating in the globe microbial identification market profiled in the report are Shimadzu Corporation, Dickinson & Company, Biolog Inc., Merck KGaA, IEH Laboratories & Consulting Group, Trivitron Healthcare, Thermo Fisher Scientific Inc., Bruker Corporation, VWR Corporation, and Charles River Laboratories International Inc.

KEY MARKET HAPPENINGS

• In May 2022, Biolog, Inc., a leading provider of cellular microbial identification, appointed a new leadership team of veteran Robert Wicke as CEO and Barry Bochner as a founder to advance its cellular analysis product portfolio, to develop and sell products in various markets like biotechnology, academic research, agriculture, and plant and animal health.
• In January 2022, BD, one of the world's leading medical technology companies, received 510(k) clearance from the US Food and Drug Administration for the BD Kiestra IdentifA System, designed to automate bacterial identification tests preparation and to select discrete bacterial colonies from a digital plate image using sophisticated robotics.

DETAILED SEGMENTATION OF THE GLOBAL MICROBIAL IDENTIFICATION MARKET INCLUDED IN THIS REPORT

This research report on the global microbial identification market has been segmented and sub-segmented into the following categories.

By Method

• Genotypic              
• Proteomics-based              
• Phenotypic

By Application 

• F&B           
• Diagnostics
• Pharmaceutical    
• Environmental

By Product                       

• Identification Services       
• Consumables        
• Instruments

By End User                     

• Food Manufacturing Industries     
• Pharmaceutical Companies             
• Hospitals and Diagnostic Centres  
• Other End-users

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa